| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e57e72a80112baa5ed1a8d21842b88d3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-53 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-07049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2006-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3941690719ac0f236fc5ca701b7a985e |
| publicationDate |
2007-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007048294-A1 |
| titleOfInvention |
Method for inhibiting telomerase activity |
| abstract |
The present application discloses a purified covalently closed antisense molecule, which specifically inhibits expression of human telomerase by specifically binding to nucleic acid encoding human telomerase. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9045750-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013052731-A1 |
| priorityDate |
2005-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |